The latest price target for PolyPid (NASDAQ:PYPD) was reported by HC Wainwright & Co. on December 16, 2024. The analyst firm set a price target for $14.00 expecting PYPD to rise to within 12 months (a possible 334.78% upside). 7 analyst firms have reported ratings in the last year.

The latest analyst rating for PolyPid (NASDAQ:PYPD) was provided by HC Wainwright & Co., and PolyPid reiterated their buy rating.

There is no last upgrade for PolyPid

The last downgrade for PolyPid Ltd happened on September 7, 2022 when Barclays changed their price target from $22 to $2.5 for PolyPid Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PolyPid, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PolyPid was filed on December 16, 2024 so you should expect the next rating to be made available sometime around December 16, 2025.

While ratings are subjective and will change, the latest PolyPid (PYPD) rating was a reiterated with a price target of $14.00 to $14.00. The current price PolyPid (PYPD) is trading at is $3.22, which is out of the analyst’s predicted range.